| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |